Labs race to make pharmaceutical MDMA available to treat mental illness

The Globe & Mail

April 15, 2023

The Globe & Mail visited Filament's lab to interview our team regarding the production of MDMA and the Special Access Program.

read more News

Filament Health Reports Q4 And Year End 2023 Financial Results And Operational Highlights

Filament Health Announces Appointment Of Michael Messinger To Its Board Of Directors